Psoriatic Arthritis Treatment Market Growth Patterns And Forecast Outlook Through 2030
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Much Growth In Market Value Is Expected For The Psoriatic Arthritis Treatment Market Between 2026 And 2030?
The psoriatic arthritis treatment market has demonstrated significant expansion over recent years. This market is anticipated to increase from $13.17 billion in 2025 to $14.36 billion in 2026, registering a compound annual growth rate (CAGR) of 9.0%. The historical growth of this market was driven by the restricted availability of advanced therapies, the reliance on conventional NSAIDs and DMARDs, the rising occurrence of psoriatic arthritis, heightened patient awareness, and the development of hospital and retail pharmacy infrastructure.
The psoriatic arthritis treatment market is projected to experience robust expansion over the coming years. This market is anticipated to reach $20.62 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.5%. Factors driving this growth during the forecast period include advancements in interleukin and JAK inhibitor development, a rise in the use of biologics, the expansion of personalized medicine strategies, increased uptake of telemedicine for managing chronic conditions, and enhanced government and insurance backing for psoriatic arthritis therapies. Key trends identified for the forecast period encompass a growing preference for biologics and targeted synthetic DMARDs, heightened recognition of the importance of early diagnosis and management for psoriatic arthritis, the evolution of tailored treatment methods for both joint and skin manifestations, the broadening of hospital and specialty pharmacy networks, and the incorporation of telemedicine alongside remote monitoring solutions for individuals with psoriatic arthritis.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3458&type=smp
What Significant Factors Are Influencing The Psoriatic Arthritis Treatment Market Expansion?
The rising healthcare spending is anticipated to stimulate the expansion of the psoriatic arthritis treatment market in the future. Healthcare spending, also referred to as healthcare expenditure, denotes the financial assets dedicated to providing healthcare services, products, and initiatives within a particular nation, region, or healthcare framework. This spending aids the diagnostic process by funding doctor visits, lab tests, and imaging studies. Individuals with PsA frequently require comprehensive evaluations to confirm their diagnosis, determine the extent of joint involvement, and identify any related conditions. As an illustration, in December 2024, the Centers for Medicare & Medicaid Services, a US-based agency managing Medicare and Medicaid, reported that U.S. health care expenditures in 2023 rose by 7.5%, reaching $4.9 trillion, or approximately $14,570 per person. Consequently, the increase in healthcare spending is fueling the growth of the psoriatic arthritis treatment market.
How Is Segmentation Applied In The Psoriatic Arthritis Treatment Market Segment Analysis?
The psoriatic arthritis treatment market covered in this report is segmented –
1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDS), Disease-Modifying Anti-Rheumatic Drugs (DMARDS), Biologics, Other Drug Classes
2) By Route Of Administration: Oral, Parenteral, Topical
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Traditional NSAIDs, COX-2 Inhibitors
2) By Disease-Modifying Anti-Rheumatic Drugs (DMARDs): Conventional DMARDs, Targeted Synthetic DMARDs
3) By Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Other Biologics
4) By Other Drug Classes: Corticosteroids, Topical Treatments, Janus Kinase (JAK) Inhibitors
Which Trends Are Impacting The Progress Of The Psoriatic Arthritis Treatment Market?
Leading companies in the psoriatic arthritis treatment market are securing approvals for new medications like Cosentyx to enhance their profitability. Cosentyx is a medication utilized to manage autoimmune conditions such as non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and enthesitis-related arthritis. For instance, in October 2023, Novartis, a Switzerland-based pharmaceutical company, announced the Food and Drug Administration had approved its new drug, Cosentyx. Cosentyx functions as a human interleukin-17A antagonist, working by preventing the activation of a protein named IL-17A, which minimizes potential patient side effects like edema, discomfort, and skin rashes. Cosentyx has demonstrated efficacy in managing psoriatic arthritis symptoms and can show effects in as little as three weeks. It alleviates several psoriatic arthritis symptoms, including joint pain and tenderness, back discomfort, and skin issues.
Who Are The Companies Participating In The Psoriatic Arthritis Treatment Market Environment?
Major companies operating in the psoriatic arthritis treatment market are AbbVie Inc., Amgen Astellas BioPharma K.K., Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Celgene Corporation, Novartis International AG, Eli Lilly and Company, Pfizer Inc., Merck & Co. Inc., AstraZeneca plc, Sanofi SA, Otsuka Pharmaceutical Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Bayer AG, Eisai Inc., Janssen Pharmaceuticals Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Chugai Pharmaceutical Co. Ltd., Kyowa Kirin Co. Ltd.
Get The Full Psoriatic Arthritis Treatment Market Report:
Where Is The Psoriatic Arthritis Treatment Market Most Concentrated Geographically?
North America was the largest region in the psoriatic arthritis treatment market in 2025. The regions covered in the psoriatic arthritis treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Psoriatic Arthritis Treatment Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Psoriatic Arthritis Treatment Market 2026, By The Business Research Company
Musculoskeletal Disorder Drugs Market Report 2026
Microbiome Therapeutics Market Report 2026
https://www.thebusinessresearchcompany.com/report/microbiome-therapeutics-global-market-report
Orthobiologics Devices And Equipment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
